The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant tislelizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis of a phase 2 study.
 
Na Zhuo
No Relationships to Disclose
 
Wei Qiu
No Relationships to Disclose
 
Jia He
No Relationships to Disclose
 
Li Li
No Relationships to Disclose
 
Qiang Wang
No Relationships to Disclose
 
Shuangni Yu
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Lin Zhao
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose